RETROVIRUSES AND IMMUNOSUPPRESSION: VIRUS VARIABILITY NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


RETROVIRUSES AND IMMUNOSUPPRESSION: VIRUS VARIABILITY

Eighteenth Meeting of the European Tumor Virus Group. April 30-May 4, 1989, Sundbyholm's Castle, Sweden, Swedish Cancer Society, 1989.. Unique Identifier : AIDSLINE ICDB/90660589
Anonymous; No affiliation given

Abstract: Abstracts are presented for the 18th European Tumor Virus Group meeting held April 30-May 4, 1989, in Sweden. Titles for the portion of the meeting covering retroviruses and immunosuppression (virus variability) include correlation between false-positive HIV serology and antibody reactivity with other primate retroviruses (distinct patterns in sera of different geographic origins), detection of antibodies against gag-proteins of type D retroviruses in sera of patients with immunodeficiency syndromes, antibodies against type D retroviruses in the sera of healthy Africans from Guinea Bissau, physical mapping of functional differences between highly cytopathic and prototype strains of HIV type 1, novel HIV-related simian immunodeficiency virus (SIV) from African green monkeys, characterization of SIV isolates from wild monkeys from the Central African Republic, spectrum of HIV strains isolated from patients in Gambia, structural analysis and biologic implication of a highly cytopathic strain of HIV-1, characterization and molecular cloning of a nonproducing HIV variant, and biologic characterization of paired HIV-1 isolates from blood and cerebrospinal fluid.
Keywords: Animal Cell Line, Transformed Cell Transformation, Viral/*IMMUNOLOGY Cytopathogenic Effect, Viral/IMMUNOLOGY Human HIV/IMMUNOLOGY HIV Infections/IMMUNOLOGY HIV-1/IMMUNOLOGY Retroviridae/*IMMUNOLOGY SIV/IMMUNOLOGY MONOGRAPHKWDanimalcellline,transformedcelltransformation,viral/KWDimmunologycytopathogeniceffect,viral/immunologyhumanhiv/immunologyhivinfections/immunologyhiv-1/immunologyretroviridae/KWDimmunologysiv/immunologymonograph
900530
M9051010

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .